BBOT
BridgeBio Oncology Therapeutics, Inc.
3.90$
-1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 1,182.7% | 1.0% | 94.9% | |
| – | – | 75.1% | 0.9% | 83.3% | |
| – | – | – | 0.9% | 94.9% | |
| – | – | – | – | 0.1% | |
| 112.7% | 115.1% | 119.1% | 2.9% | 8.3% | |
| 112.7% | 115.1% | 119.1% | 0.1% | 7.8% | |
| 25.6% | 29.8% | 21.1% | – | 0.1% | |
| – | – | 172.7% | 1.6% | 0.3% | |
| -12.7% | -15.1% | -19.1% | 97.1% | 91.7% | |
| -30.1% | -32.4% | -26.6% | -1.9% | -79.5% | |
| 14,198.0% | 14,168.8% | 6,153.6% | 0.0% | 6.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.